EUVIMEDEUVIMED entdecken
Crossref

PD-L1/SHP2 dual PROTACs inhibit melanoma by enhancing T-cell killing activity

Yang Liu, Jing Liang, Mengzhu Zheng, Haoze Song, Lixia Chen, Hua Li

Chinese Chemical Letters · 2025-06 · 36 (6) · 110317

DOI: 10.1016/j.cclet.2024.110317 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chinese Chemical Letters, 2025-06. Verfasst von Yang Liu und 5 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Fujian University of Traditional Chinese Medicine, Ministry of Education of the People's Republic of China, National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • Fujian University of Traditional Chinese Medicine
  • Ministry of Education of the People's Republic of China
  • National Natural Science Foundation of China

Zitieren

APA

Liu, Y., Liang, J., Zheng, M., Song, H., Chen, L., & Li, H. (2025). PD-L1/SHP2 dual PROTACs inhibit melanoma by enhancing T-cell killing activity. Chinese Chemical Letters, 36(6), 110317. https://doi.org/10.1016/j.cclet.2024.110317

Vancouver

Liu Y, Liang J, Zheng M, Song H, Chen L, Li H. PD-L1/SHP2 dual PROTACs inhibit melanoma by enhancing T-cell killing activity. Chinese Chemical Letters. 2025;36(6):110317. doi:10.1016/j.cclet.2024.110317

BibTeX
@article{Liu2025,
  author = {Liu, Yang and Liang, Jing and Zheng, Mengzhu and Song, Haoze and Chen, Lixia and Li, Hua},
  title = {PD-L1/SHP2 dual PROTACs inhibit melanoma by enhancing T-cell killing activity},
  journal = {Chinese Chemical Letters},
  year = {2025},
  volume = {36},
  number = {6},
  pages = {110317},
  doi = {10.1016/j.cclet.2024.110317}
}
Kostenlos starten →